As reported in the World Obesity Atlas 2024 by the World Obesity Federation, the projections for 2035 suggest that more than 1.77 billion people will be overweight, and 1.53 billion people will be affected by obesity. This will represent 54% of all adults worldwide. Obesity is a chronic complex disease defined by excessive fat deposits […]
Breaking the Weight Cycle: A New Perspective on Obesity Read More »
Radiation therapy plays a vital role in the treatment of cancer, often used alone or in combination with chemotherapy or surgery. But for as many as 95% of patients, radiation comes with a painful side effect — Radiation-Induced Dermatitis (RID). From mild redness to moist, weeping wounds, RID can impact treatment continuity and deeply affect
Radiation-Induced Dermatitis in Cancer Therapy: Causes, Challenges & Soothing Solutions Read More »
Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice Question: Are cancer patients receiving appropriate nutritional screening, assessment, and interventions? SUMMARY ANSWER: Cancer Nutrition plays a crucial role for patients with cancer; however, nutritional problems are often under-prioritised, underdiagnosed, and undertreated, thereby affecting treatment outcomes and quality of life WHAT
Good Nutrition: The Fifth Pillar Of Cancer Treatment Cancer occurs due to the uncontrolled growth of cells, which are the basic building blocks of the body. Receiving a cancer diagnosis is often a distressing experience, followed by significant pain, suffering, and heartbreak. Despite substantial advances in cancer research and management over the past few decades,
Good Nutrition : The Fifth Pillar Of Cancer Treatment Good Nutrition Read More »
Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination, however, real world evidence in the Indian patients
Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population Read More »
CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer CDK-4/6 inhibitors for the treatment of HR+/HER2 The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination. Hormone
CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer Read More »
18002029010, (+91) 9319084921
01141323176
wecare@wembrace.in
B-6/9, Commercial Complex, Safdarjung Enclave, New Delhi-110029
Don’t miss our future updates! Get Subscribed Today!
